InsiderTrades

Form 4 for VCEL Vericel Corp

Accepted 2025-02-24 00:00:00 ET · period of report 2025-02-20 · accession 0001140361-25-005660 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DT 2025-02-24 2025-02-20 VCEL Flynn Sean C. CLO S - Sale $57.32 -3,835 756 -84% -$219.8K
DMT 2025-02-24 2025-02-20 VCEL Flynn Sean C. CLO A - Grant $0.00 +49.0K 14.0K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-02-20 S D 3,835 $57.32 756 D — — (F1) The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. (F2) These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
2 Derivative Stock Option (Right to Buy) 2025-02-20 A A 35,000 $0.00 35,000 D $54.31 · — to 2035-02-20 35,000 Common Stock (F3) These options shall begin vesting on February 20, 2025 and shall continue to vest and become exercisable in equal quarterly installments over the course of the following four (4) year period.
3 Derivative Restricted Stock Unit 2025-02-20 A A 14,000 $0.00 14,000 D — · — to — 14,000 Common Stock (F4) Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation. (F5) These RSUs vest in four annual installments with the initial vesting of RSUs granted to the Reporting Person on February 20, 2026. The remaining RSUs will vest in annual installments on February 20, 2027, February 20, 2028, and February 20, 2029, respectively. (F6) No expiration date for this type of award.